Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?

Arteriosclerosis, thrombosis, and vascular biology - 1 Apr 2004

Humphries Steve E, Ridker Paul M, Talmud Philippa J

Abstract excerpt

Genetic susceptibility tests are already advertised on the Internet to identify individuals at above average risk for cardiovascular disease (CVD), such as deep vein thrombosis, hyperlipidemia, or atherosclerosis, whereas other tests claim to predict response to a particular drug treatment. Some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Cardiovascular Diseases
Share to Environmental Exposure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Genetic Testing

Share to Multifactorial Inheritance

Share to Predictive Value of Tests

Share to Risk Assessment

Source

Identifiers

PMID: 14715642
DOI: 10.1161/01.ATV.0000116216.56511.39

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14715642-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?PMID 14715642Read ↗

Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Semantic proximity Read ↗

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?Semantic proximity Read ↗

Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.Semantic proximity Read ↗

Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature ReviewSemantic proximity Read ↗

Common genetic risk factors for coronary artery disease: new opportunities for prevention?Semantic proximity Read ↗

Human genetics and its impact on cardiovascular disease.Semantic proximity Read ↗

Utility of genetic determinants of lipids and cardiovascular events in assessing risk.Semantic proximity Read ↗

Genetics of CVD in 2015: Using genomic approaches to identify CVD-causing variants.Semantic proximity Read ↗

Genetics and cardiovascular disease.Semantic proximity Read ↗

Molecular genetics and genetic epidemiology of cardiovascular diseases and diabetes. Introductory remarks: risk factor levels and variability.Semantic proximity Read ↗

Genetics of CVD in 2017: Expanding the spectrum of CVD genetics.Semantic proximity Read ↗

Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.